Efficacy News and Research

RSS
Vivolux receives FDA clearance to proceed with phase I/II clinical trial of VLX600

Vivolux receives FDA clearance to proceed with phase I/II clinical trial of VLX600

Study: Immunization program in UK has reduced HPV infections in young women

Study: Immunization program in UK has reduced HPV infections in young women

Low-cost empowerment program for adolescent girls sharply curtails sexual harassment

Low-cost empowerment program for adolescent girls sharply curtails sexual harassment

Amrubicin regimen inferior to irinotecan for extensive SCLC

Amrubicin regimen inferior to irinotecan for extensive SCLC

Tau Therapeutics presents data of T-type calcium channel inhibitors in treatment of pancreatic cancer

Tau Therapeutics presents data of T-type calcium channel inhibitors in treatment of pancreatic cancer

New Dartmouth study offers roadmap for better risk adjustment in Medicare

New Dartmouth study offers roadmap for better risk adjustment in Medicare

Scientists report successful nose reconstruction surgery using cartilage grown in laboratory

Scientists report successful nose reconstruction surgery using cartilage grown in laboratory

Compressyn Band selected as finalist in Medical Design Excellence Awards for Implant and Tissue-Replacement Products Category

Compressyn Band selected as finalist in Medical Design Excellence Awards for Implant and Tissue-Replacement Products Category

New edition of RADAR includes review of glycopyrronium for COPD treatment

New edition of RADAR includes review of glycopyrronium for COPD treatment

BioLineRx to initiate Phase 1/2 clinical trial on new drug candidate for CML treatment

BioLineRx to initiate Phase 1/2 clinical trial on new drug candidate for CML treatment

Red LED irradiation promotes cell transplantation in treatment of hypoxic-ischemic brain damage

Red LED irradiation promotes cell transplantation in treatment of hypoxic-ischemic brain damage

Dosage and schedules may improve effects of PI3K-inhibitors to target breast cancer tumors

Dosage and schedules may improve effects of PI3K-inhibitors to target breast cancer tumors

Affimed Therapeutics reports additional results from AFM13 phase 1 study on R/R Hodgkin lymphoma

Affimed Therapeutics reports additional results from AFM13 phase 1 study on R/R Hodgkin lymphoma

Stem cells culled from bone marrow may prove beneficial in stroke recovery

Stem cells culled from bone marrow may prove beneficial in stroke recovery

UCSF launches Brain Health Registry to advance neuroscience research

UCSF launches Brain Health Registry to advance neuroscience research

Herpes simplex viral therapy in conjunction with radiation proves effective in treating malignant gliomas

Herpes simplex viral therapy in conjunction with radiation proves effective in treating malignant gliomas

ImmunoGen presents first findings aimed at optimizing dosage of IMGN853 product candidate

ImmunoGen presents first findings aimed at optimizing dosage of IMGN853 product candidate

Researchers identify novel compound effective against drug-resistant lung cancer

Researchers identify novel compound effective against drug-resistant lung cancer

Alkermes announces results from phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia

Alkermes announces results from phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia

PeptiDream develops novel macrocyclic peptide inhibitor for treatment of multiple influenza strains

PeptiDream develops novel macrocyclic peptide inhibitor for treatment of multiple influenza strains

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.